To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb — HU-014

Post Stroke Upper Limb Spasticity Clinical Trial

Official title:
Multi Center, Phase III Clinical Trial to Evaluate the Safety and Efficacy of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity

Status Completed

Clinical Trial Summary

Investigational Product: LIZTOX inj 100unit(HU-014) Title : Multi Center, Phase III Clinical Trial to Evaluate the efficacy and Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity Sites and investigators : Asan Medical Center(Seoul), Min-ho Chun, M.D, Ph.D Objective : To evaluate the efficacy and safety of LIZTOX inj in the treatment of Post Stroke Upper Limb Spasticity

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Muscle Spasticity
Post Stroke Upper Limb Spasticity
Stroke

Clinical Trial Details

NCT number	NCT05289921
Study type	Interventional
Source	Huons Co., Ltd.
Contact
Status	Completed
Phase	Phase 3
Start date	March 4, 2022
Completion date	March 7, 2023

View Details

See also
	Status	Clinical Trial	Phase
	Enrolling by invitation	`NCT04415346` - A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity	Phase 1